Sarah Cheal   Assistant Professor of Biological Chemistry in Radiology

Publications

Sort by

selected publications

Research

Sort by

Funding awarded

  • An engineered bacterial reporter gene fusion for radiotheranostics  awarded by National Cancer Institute Principal Investigator 2024 - 2026
  • DOTA-based pre-targeting of alpha emitters  awarded by National Cancer Institute Principal Investigator 2022 - 2024
  • Preclinical Development of Trop2 Directed ImmunoPET Tracer for Prostate Cancer.  awarded by Conquer Cancer Foundation of the American Society of Clinical Oncology Key Personnel 2024 - 2025
  • Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture  awarded by Stand Up To Cancer Principal Investigator Subaward 2022 - 2026

Background

Contact

full name

  • Sarah Cheal

primary email

  • smc4002@med.cornell.edu

External Relationships

externalRelationships

  • Relationships and collaborations with for-profit and not-for-profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

    Ownership refers to any financial stake an individual owns in any company (e.g., stock options, equity interest)Ownership:
    Actinium Pharmaceuticals, Inc.